Literature DB >> 14671483

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.

Christian Mathy1, Ken Schneider, Yunn-Yi Chen, Madhulika Varma, Jonathan P Terdiman, Uma Mahadevan.   

Abstract

OBJECTIVE: The gross extent of ulcerative colitis (UC) is a recognized risk factor for the development of colitis-related dysplasia and colorectal cancer (CRC). The risk of neoplasia associated with the microscopic extent of colitis is unknown. The aim of this study was to describe the gross and microscopic extent of colitis in patients with UC-related dysplasia/CRC.
METHODS: All patients who underwent colectomy at our institution between 1992-2001 with colitis-related dysplasia/CRC were identified. Histological sections from each colectomy specimen were reviewed for the microscopic extent of colitis and the location of all lesions with dysplasia/CRC.
RESULTS: Thirty-six patients with colitis-related dysplasia/CRC were identified of whom 30 had slides available for review. Gross pancolitis was identified in 19 patients, though microscopic pancolitis was evident in all 30 patients. Among the 11 patients with only distal gross colitis, 4/15 neoplastic lesions were proximal to the area of gross involvement.
CONCLUSIONS: UC-related neoplasia can occur in areas of the colon not grossly involved with colitis, though it did not occur in any patients without microscopic pancolitis. To devise rational cancer surveillance guidelines, further studies are needed to determine the risk of colitis-related neoplasia in patients with microscopic pancolitis but limited gross disease.

Entities:  

Mesh:

Year:  2003        PMID: 14671483     DOI: 10.1097/00054725-200311000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  21 in total

Review 1.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

2.  Colorectal cancer in inflammatory bowel disease.

Authors:  Jonathan Potack; Steven H Itzkowitz
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

3.  A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis.

Authors:  Renée M Marchioni Beery; Thomas J Devers; Jessica M Clement
Journal:  Gastrointest Cancer Res       Date:  2014-05

4.  Relationship between methylation and colonic inflammation in inflammatory bowel disease.

Authors:  Triana Lobatón; Daniel Azuara; Francisco Rodríguez-Moranta; Carolina Loayza; Xavier Sanjuan; Javier de Oca; Ana Fernández-Robles; Jordi Guardiola; Gabriel Capellá
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 6.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

Review 7.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

8.  O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.

Authors:  Julia Kargl; Johannes Haybaeck; Angela Stančić; Liisa Andersen; Gunther Marsche; Akos Heinemann; Rudolf Schicho
Journal:  J Mol Med (Berl)       Date:  2012-09-11       Impact factor: 4.599

Review 9.  Status of colitis-associated cancer in ulcerative colitis.

Authors:  Tetsushi Kinugasa; Yoshito Akagi
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

10.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

Authors:  Roopali Bansal Gupta; Noam Harpaz; Steven Itzkowitz; Sabera Hossain; Sierra Matula; Asher Kornbluth; Carol Bodian; Thomas Ullman
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.